Potential Treatment Options
Closed-loop neuromodulation: EEG/MEG or future higher-resolution sensors identify the abnormal activity pattern and stimulation is delivered only when needed.
Focused ultrasound neuromodulation (tFUS): potentially modulating deeper or very specific visual-network targets without surgery. This remains experimental for this purpose.
High-definition TMS/tDCS: increasingly individualized stimulation of visual cortex based on each person's functional connectivity.
Temporal-interference stimulation: an experimental approach aimed at noninvasively influencing deeper neural circuits.
Precision pharmacology: drugs designed to normalize particular excitatory/inhibitory mechanisms—such as glutamate, GABA, or specific ion channels—with fewer whole-brain effects.
Activity-guided treatment: advanced MEG/fMRI or future optical/electromagnetic imaging could potentially identify your particular phosphene network, allowing stimulation to be tailored to it.
Closed-loop implanted stimulation: farther out, very small cortical interfaces could detect pathological visual activity and suppress it electrically, somewhat analogous to responsive neurostimulation used for epilepsy.